Adverts

Open Access Articles- Top Results for Labetuzumab

Labetuzumab

Labetuzumab?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target carcinoembryonic antigen
Clinical data
Identifiers
219649-07-7 7pxN
None
KEGG D08936 7pxY
Chemical data
 14pxN (what is this?)  (verify)

Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer.[1] It selectively binds to carcinoembryonic cell adhesion molecule 5. [2]

This drug was developed by Immunomedics, Inc.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The Usan Council - Labetuzumab, American Medical Association.
  2. ^ http://www.cancer.gov/drugdictionary?cdrid=692828


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.